Clopidogrel Hydrogen Sulfate Tablets

Clopidogrel, an ADP receptor antagonist, prevents ADP from binding to ADP receptors on platelets, thereby inhibiting the interaction between glycoprotein IIb/IIIa receptors and fibrinogen and ultimately suppressing platelet aggregation. It is used for the prevention and treatment of cardiovascular, cerebrovascular, and other arterial circulation disorders caused by excessive platelet aggregation, such as recently occurred stroke, myocardial infarction, and confirmed peripheral artery disease.

Category:

Cardiovascular and cerebrovascular products

Return to list

Detailed introduction

Clopidogrel, as ADP Receptor antagonist, blocks ADP With platelets ADP Receptor binding prevents glycoproteins IIb/IIIa The receptor binds to fibrinogen, thereby inhibiting platelet aggregation. It is used for the prevention and treatment of cardiovascular, cerebrovascular, and other arterial circulation disorders caused by excessive platelet aggregation, such as recently occurring cases. Stroke 、 Myocardial infarction And diagnosed peripheral artery disease 。